RECURRENT POLYSINUSITIS AS LEADING CLINICAL EVIDENCE OF CYSTIC FIBROSIS. SUCCESSFUL ENDONASAL APPLICATION OF DORNASE ALFA

I.K. Asherova; V.V. Tarakanova

RECURRENT POLYSINUSITIS AS LEADING CLINICAL EVIDENCE OF CYSTIC FIBROSIS. SUCCESSFUL ENDONASAL APPLICATION OF DORNASE ALFA

I.K. Asherova, V.V. Tarakanova

Abstract
About the Authors
Cited By
Scopus Cited

About the Authors

I.K. Asherova

Municipal Health-Care Institution «Children’s Clinical Hospital No. 1», Yaroslavl
Russian Federation

V.V. Tarakanova

Municipal Health-Care Institution «Children’s Clinical Hospital No. 1», Yaroslavl
Russian Federation

Review

For citations:

Asherova I., Tarakanova V. RECURRENT POLYSINUSITIS AS LEADING CLINICAL EVIDENCE OF CYSTIC FIBROSIS. SUCCESSFUL ENDONASAL APPLICATION OF DORNASE ALFA. Pediatric pharmacology. 2009;6(5):88-91.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pediatric pharmacology

RECURRENT POLYSINUSITIS AS LEADING CLINICAL EVIDENCE OF CYSTIC FIBROSIS. SUCCESSFUL ENDONASAL APPLICATION OF DORNASE ALFA

About the Authors

Review

For citations:

Cookies policy